AzTrials
AzTrials

Anterior Glenohumeral DislocationsNCT05898243

Prospective Descriptive Study of Injuries Associated to Anterior Shoulder Dislocations in Patients Over 40 Years

An observational study of Anterior Glenohumeral Dislocations, run by Corporacion Parc Tauli at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The glenohumeral joint has the highest rate of dislocation of the whole body, due to its high mobility and the special characteristics of its anatomy. It is estimated that every year between 1-2% of the population will suffer from glenohumeral dislocation. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Anterior Glenohumeral Dislocations
What is being tested?
Reduction
Type of treatment
Surgery or procedure
How many people
120 participants
Where
1 siteSpain
Study dates
1 Jun 2023to 31 May 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All consecutive patients with an anterior glenohumeral dislocation and over 40 years old who came to the Emergency Room in the Hospital between June 2023 and June 2025

Who may be able to join

  • More than 40 years old
  • First episode of traumatic anterior gelnohumeral dislocation seen in Rx
  • Acceptance to be checked over 2 years
  • Acceptance to be submitted to TAC, NMR, EMG and Bilateral Ultrasound

Who cannot join

  • Previous fractures in this extremity
  • Previous neurovascular lesions in this extremity
  • Other associated lesions
  • Cognitive alterations or dementia which prevent completing the protocols. Patients with <14 points in Mini-mental test.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Spain1 site, 1 recruiting
  • Hospital Parc Taulí

    Sabadell, Barcelona, 08208

    Mireia, 34 93 723 10 10 ext. 21652

    Recruiting

Other trials in Spain

About this study

The glenohumeral joint has the highest rate of dislocation of the whole body, due to its high mobility and the special characteristics of its anatomy. It is estimated that every year between 1-2% of the population will suffer from glenohumeral dislocation. The vast majority of studies are based on young patients under the age of 40, given that at this age they have the higher incidence and at the same time, they have higher redislocation index. However, the investigators are in front of a more active population with a longer life expectancy. That is why the cases of anterior glenohumeral dislocations are increasing in people older than 40 years. Given that most studies focus on younger patients, the investigators lack knowledge about which injuries are associated with dislocation at this age and whether these influence its clinical evolution.

Being tested
Reduction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReductionProcedure or surgery

    An Rx will be performed before and after the reduction of the dislocation. After that, the neurovascular state will be checked and also if there is some associated injury.

Study groups in NCT05898243
Study groupRoleWhat they receive
Humeral anterior dislocationPatients presenting a first episode of humeral anterior dislocation and who are over 40 years old.
Receives: Procedure: Reduction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Characterization of associated lesions

    Measured: At the three months visit including assessment of NMR/EMG/TAC/Bilateral Ultrasound

Secondary outcomes (5)
  1. Constant Functional Test

    Measured: 3, 6, 12 and 24 months

  2. WOSI test

    Measured: 3, 6, 12 and 24 months

  3. SST

    Measured: 3, 6, 12 and 24 months

  4. Redislocations

    Measured: 3, 6, 12 and 24 months

  5. Type of treatment

    Measured: 3, 6, 12 and 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2023
  2. Study start1 Jun 2023
  3. Primary completion31 May 2028 (estimated)
  4. Study completion31 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05898243
Sponsor's protocol ID
Dislocation
Status last verified
Oct 2026
First submitted
1 Jun 2023
Last updated
23 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Smartt AA, Wilbur RR, Song BM, Krych AJ, Okoroha K, Barlow JD, Camp CL. Natural History of First-Time Anterior Shoulder Dislocation in Patients Older Than 50 Years: A Study of 179 Patients With a Mean Follow-up of 11 Years. Orthop J Sports Med. 2022 Nov 2;10(11):23259671221129301. doi: 10.1177/23259671221129301. eCollection 2022 Nov.

    PubMed 36339796
  • Rapariz JM, Martin-Martin S, Pareja-Bezares A, Ortega-Klein J. Shoulder dislocation in patients older than 60 years of age. Int J Shoulder Surg. 2010 Oct;4(4):88-92. doi: 10.4103/0973-6042.79792.

    PubMed 21655003
  • Robinson CM, Shur N, Sharpe T, Ray A, Murray IR. Injuries associated with traumatic anterior glenohumeral dislocations. J Bone Joint Surg Am. 2012 Jan 4;94(1):18-26. doi: 10.2106/JBJS.J.01795.

    PubMed 22218378
  • Maier M, Geiger EV, Ilius C, Frank J, Marzi I. Midterm results after operatively stabilised shoulder dislocations in elderly patients. Int Orthop. 2009 Jun;33(3):719-23. doi: 10.1007/s00264-008-0578-z. Epub 2008 May 24.

    PubMed 18500515
  • Atef A, El-Tantawy A, Gad H, Hefeda M. Prevalence of associated injuries after anterior shoulder dislocation: a prospective study. Int Orthop. 2016 Mar;40(3):519-24. doi: 10.1007/s00264-015-2862-z. Epub 2015 Jul 2.

    PubMed 26133290
  • Sonnabend DH. Treatment of primary anterior shoulder dislocation in patients older than 40 years of age. Conservative versus operative. Clin Orthop Relat Res. 1994 Jul;(304):74-7.

    PubMed 8020237
  • Liavaag S, Stiris MG, Svenningsen S, Enger M, Pripp AH, Brox JI. Capsular lesions with glenohumeral ligament injuries in patients with primary shoulder dislocation: magnetic resonance imaging and magnetic resonance arthrography evaluation. Scand J Med Sci Sports. 2011 Dec;21(6):e291-7. doi: 10.1111/j.1600-0838.2010.01282.x. Epub 2011 Mar 15.

    PubMed 21401723
  • Stayner LR, Cummings J, Andersen J, Jobe CM. Shoulder dislocations in patients older than 40 years of age. Orthop Clin North Am. 2000 Apr;31(2):231-9. doi: 10.1016/s0030-5898(05)70143-7.

    PubMed 10736392
  • Shin SJ, Yun YH, Kim DJ, Yoo JD. Treatment of traumatic anterior shoulder dislocation in patients older than 60 years. Am J Sports Med. 2012 Apr;40(4):822-7. doi: 10.1177/0363546511434522. Epub 2012 Jan 27.

    PubMed 22287643

Questions about this trial

What is this clinical trial studying?

An observational study of Anterior Glenohumeral Dislocations, run by Corporacion Parc Tauli at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mònica Salomó (+34 93 723 10 10 ext. 21611, msalomo@tauli.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Characterization of associated lesions (time frame: At the three months visit including assessment of NMR/EMG/TAC/Bilateral Ultrasound). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05898243, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in